Navigation Links
Spheris Reports Fourth Quarter and Year-End 2007 Results
Date:3/26/2008

Webcast

Spheris will host a conference call on March 27, 2008, at 8 a.m. CT. The number to call for this interactive teleconference is (800) 240-4186. Following the conference call, the audio replay will be available for one week by dialing (303) 590-3000 and entering the confirmation number 11106043#. The live broadcast of Spheris' quarterly conference call will be available online at http://www.spheris.com and http://www.videonewswire.com/event.asp?id=44839 on March 27, 2008, at 8 a.m. CT. The online replay will be available on Spheris' Web Site shortly after the call and will continue for 30 days.

About Spheris

Spheris is a leading global outsource provider of clinical documentation technology and services to more than 500 health systems, hospitals and group practices throughout the U.S. Spheris offers a highly advanced, Web-based technology platform, available as an independent solution to support in-house departments or blended with Spheris' outsource services. Spheris employs approximately 5,500 skilled medical language specialists supporting the Company's clients through a secure network. Using a Follow the Sun(SM) service strategy, customer support is provided 24 hours a day, 365 days a year with an emphasis on verifiable quality, turnaround time and pricing. Spheris' world- wide corporate headquarters are located in Franklin, Tenn. For more information, please visit http://www.spheris.com.

Forward-Looking Statements

This press release contains statements as to the Company's beliefs and expectations of the outcome of future events that are forward-looking statements as defined within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties as described in the filings
'/>"/>

SOURCE Spheris
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Spheris Sets Fourth Quarter 2007 Earnings Release and Conference Call Dates
2. Spheris Elects New Board Member
3. NeurogesX Reports Fourth Quarter and Year-End 2007 Financial Results
4. QMed, Inc. Reports Year-End and Fourth Quarter Results
5. Pelosi Statement on Social Security and Medicare Trustees Reports
6. NASI Experts Available to Comment on 2008 Social Security and Medicare Trustees Reports
7. SPO Medical Reports 2007 Sales: Growth of 35% Compared to 2006
8. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
9. U.S. Army Study Reports WoundStat(TM) is Most Effective
10. CryoCor Reports 2007 Results
11. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...At a symposium today hosted by Johns,Hopkins Uni...earchers presented,the latest research in brain p...science into technology to improve lives. Henry Ma...evidence that cognitive intervention developed by,... brain,s ability to,reorganize itself throughout ...
(Date:12/2/2008)...Newswire/ -- Are you unhappy with your smile but a...vailable? , , The Pennsylvania Dental Assoc...options exist to improve your smile. Your dentist ...o determine a suitable option to help restore your...ntal options. , , , , Tooth wh...
(Date:12/2/2008)...ted for 3.5 percent of high school athletes, injur...y to examine rare injuries and conditions of U.S. ...juries, dental injuries, neck and cervical injurie...lt in high morbidity, costly surgeries and treatme...s associated with the highest rate of rare injurie...
(Date:12/2/2008)...ire/ -- In an open letter to President-elect Barac...s for the Aging (AAHSA) President and CEO Larry Mi...stration can make both short-term gains and develo... its most vulnerable people. , , These fou...rce: Create Jobs in Aging Services; , Construc...
Breaking Medicine News(10 mins):Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2
...Barbara Clark, who won the case that allowed her t...atment showed positive signs of recovery from the ...g for four months. But also said that there is a...back. She was diagnosed with HER2-positive breast ...
...An exhaustive genetic study conducted on more than...ysteries associated with earwax. // It could event...e some others have a sticky, brown exudate. The s...ple from either a European or African descent tend...
...Due to shortage of services in a hospital at Brisb...minutes away. Although he was attacked and was in ...e hospital in question is // the Caboolture Hospit...due to shortage of doctors. While the emergency wa...
...WASHINGTON - The Disease Management Association of...ramme that aims to uniformly measure and evaluate ..." "This certainly stands among // the disease ma...search efforts to date,” Don Fetterolf, MD, chair ...
Other Medicine News:Health News:Dry Earwax Mystery Solved: Ear Wax Gene Identified 2Health News:DMAA to Develop Disease Management Standards by December 2
(Date:12/1/2008)...ude study shows the Prox1 gene is a two-way switch... cells to be reprogrammed so that they lose their ...lls , , MEMPHIS, Tenn., Dec. 1 /PRNewswire-...Research Hospital have discovered that a certain d...identity that it requires the constant expression ...
(Date:12/1/2008)...UTH MEETING, Pa., Dec. 1 ...unced that dosing of subjects has begun in study M...ose Phase 1b study of trodusquemine (MSI-1436) in ... a novel therapeutic for the treatment of type 2 d...pherally to regulate insulin and leptin pathways t...
(Date:12/1/2008)...nference Call Scheduled for Tuesday, December 9 at...ML -- , , SOUTH SAN FRANCISCO, Calif., Dec...icals, Inc. (Nasdaq: SNSS ), a biopharmaceutical...ization of new oncology therapeutics, today announ...e myeloid leukemia (AML) will be presented during ...
(Date:12/1/2008)...IEGO, Dec. 1 Vical Incor...ipt of a $1.0 million milestone payment from Merck...on of a Phase I clinical trial of an investigation...e vaccine is based on Vical,s DNA gene delivery te...scriptase (hTERT). hTERT is the subject of separat...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2 26 23163 3B28 5M investment for groundbreaking new research facility 24358 1 26 23163 3B28 5M investment for groundbreaking new research facility 24358 2Study 3A Typhoons bury tons of carbon in the oceans 4184 1Study 3A Typhoons bury tons of carbon in the oceans 4184 2Study 3A Typhoons bury tons of carbon in the oceans 4184 3Study 3A Typhoons bury tons of carbon in the oceans 4184 4The Connecticut Hospice Inc Announces the Arrival of Six Nurse Scholars From The Henrietta Szold Hadassah Hebrew University School of Nursing 24355 1SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 1SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 2SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 3SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 4
...ed, the Hutchison Whampoa backed pharmaceutical an...ts for its Phase II,proof-of-concept study for HMP...rm of inflammatory bowel disease. The trial met,i...nd showed an,equivalent drop in clinical symptom s...nt first-line standard of care in,mild-to-moderate...
... Pharmaceuticals (AIM:CEN),("CeNeS" or "the Compan...today announced that a paper published this week i...t a,catechol-O-methyltransferase (COMT) inhibitor ...address profound cognitive,deficits in schizophren...overy programme to develop novel COMT inhibitors. ...
Other Medicine Technology:Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 2Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 3Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 4
It has long been a standard requirement for smoke evacuation to be used during laser procedures, however, many in the healthcare industry contend that smoke plume generated from electrosurgical proce
Erbium Laser with Sapphire Erbium Handpiece for Dermatological and Cosmetic Surgery
...e Dornier Medilas D Fibertom is a 60 watt diode co...use of Diode Power Bar technology and 940 nm wavel...ous laser treatment for varicose veins and a varie...m also includes unique safety features including t...
imEXPRESS uses the control panel and setup wizard concept (familiar to any Windows user) allowing you to quickly and easily connect and control your instruments.
Medicine Products: